Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
Capital Medical University · Beijing Tian Tan Hospital · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
284
total citations
- FWCI
- 57.94
- Percentile
- 100%
- References
- 25
Citations per year
Authors
75- YWYongjun Wang
Capital Medical University, Beijing Tian Tan Hospital, National Clinical Research Center for Digestive Diseases
- YWYongjun WangCorresponding
Capital Medical University, Beijing Tian Tan Hospital, National Clinical Research Center for Digestive Diseases
- SLShuya Li
Capital Medical University, Beijing Tian Tan Hospital, National Clinical Research Center for Digestive Diseases
- YPYuesong Pan
Capital Medical University, Beijing Tian Tan Hospital, National Clinical Research Center for Digestive Diseases
- HLHao Li
Liverpool Hospital, UNSW Sydney, Beijing Tian Tan Hospital, National Clinical Research Center for Digestive Diseases, Ingham Institute, South Western Sydney Local Health District
Topics & keywords
Topics
Keywords
- Medicine
- Tenecteplase
- Modified Rankin Scale
- Thrombolysis
- Stroke (engine)
- Clinical endpoint
- Fibrinolytic agent
- Randomized controlled trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.